Gavin Wood has been named the new President and CEO of Coloplast, starting May 1, 2026. The shift in leadership signifies a new chapter for the global MedTech firm, which aims to create healthcare solutions that enhance the lives of individuals with personal medical needs. In his statement after the announcement, Wood highlighted Coloplast’s robust legacy, creative portfolio, and distinct mission.
He expressed his excitement about guiding the company’s ongoing expansion while enhancing its emphasis on innovation, talent development, and sustainable value creation. Wood emphasized his dedication to furthering the company’s Impact4 strategy, designed to create sustainable value and beneficial impacts for stakeholders, customers, healthcare providers, and patients worldwide. Wood has extensive experience in the international medical technology industry.
Throughout his career, he has held senior leadership positions in several global companies and has effectively managed large commercial enterprises. His knowledge of the healthcare markets in Europe and the U.S. is anticipated to aid Coloplast in its global growth and strategic goals. Jette Nygaard-Andersen, interim chair of the Coloplast Board, stated that Wood’s strong commercial skills and leadership background position him well to lead the company in its upcoming phase of growth and value enhancement.
